SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,660.00
Ask:
5,680.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Interim Management Statement

30 Jan 2014 07:00

RNS Number : 8403Y
Cranswick PLC
30 January 2014
 

30 January 2014

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Third quarter interim management statement

 

Cranswick, the UK food producer, today provides an interim management statement for the period from 1 October 2013 to 29 January 2014.

 

Current trading

 

The Company benefited from a strong sales performance in the three months to 31 December 2013.

 

Underlying revenue in the three months to 31 December 2013 was 13 per cent ahead of the same period last year, maintaining the momentum established in the first half of the year.

 

Total sales for the quarter were 14 per cent higherafter taking into account modest third party sales made by Wayland Farms which was acquired on 29 April 2013, primarily to meet internal requirements.

 

Recent market data highlighted growth in pork consumption during the third quarter, particularly of roasting joints, with this momentum maintained over the Christmas trading period. Both the versatility and the low relative price of pork compared to other proteins were central to this positive trend. The on-going popularity of pork products continues to be a contributory factor in the increase in sales at Cranswick.

 

Sales of pastry products continued to make pleasing progress and were augmented by the launch of a range of savoury filled gourmet pies at the start of the third quarter and an exciting Christmas offering, both of which performed strongly. The focus is now on achieving the forecast returns from the investment in the new facility at Malton, North Yorkshire.

 

Input costs remained at record highs during the period, but efficiency improvements, internal pig production and constructive pricing discussions with customers helped to partially mitigate the full impact. Consequently, there was some recovery in operating margin# in the third quarter from that reported in the first half, although for the year to date it remains below that achieved in the comparable period last year.

 

During the period the Group made a further strategic investment in its pig breeding and rearing activities through the purchase, on 19 December 2013, of two additional breeding units. The total number of pigs produced internally is now 20 to 25 per cent of weekly requirements. This gives the Group greater control over a robust and integrated supply chain, with a clear focus on premium British ingredients and, in addition, has offset some of the impact of higher input costs.

 

Financial position

 

Following the expected seasonal increase in working capital, the substantial uplift in sales, further investment in the Group's pig breeding and rearing activities, and on-going capital expenditure, net debt increased from £37 million to £55 million during the quarter, with the operating cash outflow in the period following a similar pattern to previous years. Notwithstanding the investment in the Group's pig rearing and breeding activities during the year, net debt was just £7 million higher than at the equivalent quarter end last year. The Group is in a strong financial position, with committed, unsecured facilities of £100 million which provide generous headroom going forward.

 

Outlook

The business has a well invested asset base, loyal and skilled teams, a great range of products and a strong financial position. The Board looks forward positively to the rest of the year and the long term development of Cranswick.

 

 

Enquiries:

 

CityRoad Communications +44 (0) 20 7248 8010

Paul Quade +44 (0) 7947 186 694

 

 

Notes:

1. Cranswick's activities are focused within the UK and include the breeding and rearing of premium British pigs, together with the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2013 showed sales of £875m and profit before tax of £47.4m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement represents Cranswick's third quarter Interim Management Statement for the period from 1 October 2013 to 29 January 2014.

4. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

# excluding net IAS 41 valuation movement on biological assets in the current financial year and non-recurring items in both the current and prior financial years

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUKUKRSOAAUAR
Date   Source Headline
24th Nov 20254:59 pmRNSDirector/PDMR Shareholding
3rd Nov 20255:44 pmRNSHolding(s) in Company
3rd Nov 202510:40 amRNSTotal Voting Rights
22nd Oct 20252:06 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSTotal Voting Rights
23rd Sep 20254:31 pmRNSDirector/PDMR Shareholding
17th Sep 20254:43 pmRNSHolding(s) in Company
15th Sep 20258:35 amRNSDirector/PDMR Shareholding
15th Sep 20258:33 amRNSDirector/PDMR Shareholding
11th Sep 202511:30 amRNSTotal Voting Rights
5th Sep 20254:03 pmRNSHolding(s) in Company
4th Sep 20257:56 amRNSHolding(s) in Company
2nd Sep 20255:00 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSHolding(s) in Company
26th Aug 20259:23 amRNSDirector/PDMR Shareholding
26th Aug 20257:07 amRNSHolding(s) in Company
4th Aug 20259:55 amRNSTotal Voting Rights
28th Jul 20252:51 pmRNSPoll Result for 2025 Annual General Meeting
28th Jul 20257:00 amRNSFirst quarter trading statement
24th Jul 20252:46 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSDirector/PDMR Shareholding
22nd Jul 20251:45 pmRNSHolding(s) in Company
9th Jul 20252:58 pmRNSDirector/PDMR Shareholding
8th Jul 20253:23 pmRNSTotal Voting Rights
8th Jul 20253:17 pmRNSDirector/PDMR Shareholding
30th Jun 202510:00 amRNSDirector/PDMR Shareholding
30th Jun 20259:57 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSAnnual Report and Accounts and Notice of AGM
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20253:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:48 pmRNSTotal Voting Rights
27th May 20257:00 amRNSHolding(s) in Company
22nd May 20256:25 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSPreliminary Results
13th May 20252:59 pmRNSHolding(s) in Company
6th May 20254:20 pmRNSHolding(s) in Company
25th Apr 202510:11 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSDirector/PDMR Shareholding
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20258:58 amRNSTotal Voting Rights
26th Mar 20254:08 pmRNSHolding(s) in Company
26th Mar 20252:22 pmRNSDirector/PDMR Shareholding
25th Mar 20254:12 pmRNSDirector/PDMR Shareholding
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.